Logo image of RUN

SUNRUN INC (RUN) Stock Fundamental Analysis

USA - NASDAQ:RUN - US86771W1053 - Common Stock

17.61 USD
+1.03 (+6.21%)
Last: 9/22/2025, 9:04:14 PM
17.59 USD
-0.02 (-0.11%)
After Hours: 9/22/2025, 9:04:14 PM
Fundamental Rating

3

RUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 92 industry peers in the Electrical Equipment industry. RUN may be in some trouble as it scores bad on both profitability and health. RUN is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RUN was profitable.
In the past year RUN has reported a negative cash flow from operations.
In the past 5 years RUN reported 4 times negative net income.
RUN had a negative operating cash flow in each of the past 5 years.
RUN Yearly Net Income VS EBIT VS OCF VS FCFRUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

RUN has a Return On Assets (-12.09%) which is comparable to the rest of the industry.
RUN has a Return On Equity of -87.73%. This is in the lower half of the industry: RUN underperforms 60.87% of its industry peers.
Industry RankSector Rank
ROA -12.09%
ROE -87.73%
ROIC N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
RUN Yearly ROA, ROE, ROICRUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

RUN has a Gross Margin (19.71%) which is in line with its industry peers.
RUN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
RUN Yearly Profit, Operating, Gross MarginsRUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
RUN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RUN has been increased compared to 5 years ago.
RUN has a worse debt/assets ratio than last year.
RUN Yearly Shares OutstandingRUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RUN Yearly Total Debt VS Total AssetsRUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.07, we must say that RUN is in the distress zone and has some risk of bankruptcy.
RUN has a Altman-Z score (-0.07) which is comparable to the rest of the industry.
RUN has a Debt/Equity ratio of 4.72. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RUN (4.72) is worse than 80.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.72
Debt/FCF N/A
Altman-Z -0.07
ROIC/WACCN/A
WACC5.17%
RUN Yearly LT Debt VS Equity VS FCFRUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

RUN has a Current Ratio of 1.41. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RUN (1.41) is comparable to the rest of the industry.
RUN has a Quick Ratio of 1.02. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
RUN has a Quick ratio (1.02) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.02
RUN Yearly Current Assets VS Current LiabilitesRUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

7

3. Growth

3.1 Past

RUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 136.26%, which is quite impressive.
The Earnings Per Share has been growing by 42.86% on average over the past years. This is a very strong growth
Looking at the last year, RUN shows a small growth in Revenue. The Revenue has grown by 3.27% in the last year.
The Revenue has been growing by 18.87% on average over the past years. This is quite good.
EPS 1Y (TTM)136.26%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%94.55%
Revenue 1Y (TTM)3.27%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%8.68%

3.2 Future

RUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.82% yearly.
Based on estimates for the next years, RUN will show a quite strong growth in Revenue. The Revenue will grow by 10.09% on average per year.
EPS Next Y-18.68%
EPS Next 2Y-33.95%
EPS Next 3Y-23.37%
EPS Next 5Y31.82%
Revenue Next Year9.86%
Revenue Next 2Y9.35%
Revenue Next 3Y11.22%
Revenue Next 5Y10.09%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RUN Yearly Revenue VS EstimatesRUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
RUN Yearly EPS VS EstimatesRUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.62 indicates a rather cheap valuation of RUN.
RUN's Price/Earnings ratio is rather cheap when compared to the industry. RUN is cheaper than 97.83% of the companies in the same industry.
When comparing the Price/Earnings ratio of RUN to the average of the S&P500 Index (27.41), we can say RUN is valued rather cheaply.
A Price/Forward Earnings ratio of 33.92 indicates a quite expensive valuation of RUN.
Based on the Price/Forward Earnings ratio, RUN is valued a bit cheaper than the industry average as 68.48% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, RUN is valued a bit more expensive.
Industry RankSector Rank
PE 7.62
Fwd PE 33.92
RUN Price Earnings VS Forward Price EarningsRUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RUN indicates a somewhat cheap valuation: RUN is cheaper than 63.04% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 93.14
RUN Per share dataRUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

RUN's earnings are expected to decrease with -23.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-33.95%
EPS Next 3Y-23.37%

More info and screens

0

5. Dividend

5.1 Amount

RUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (9/22/2025, 9:04:14 PM)

After market: 17.59 -0.02 (-0.11%)

17.61

+1.03 (+6.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners119.83%
Inst Owner Change0.68%
Ins Owners9.15%
Ins Owner Change3.29%
Market Cap4.06B
Analysts71.33
Price Target14.47 (-17.83%)
Short Float %25.84%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)373.8%
Min EPS beat(2)168.55%
Max EPS beat(2)579.04%
EPS beat(4)3
Avg EPS beat(4)309.16%
Min EPS beat(4)-157.51%
Max EPS beat(4)646.57%
EPS beat(8)5
Avg EPS beat(8)-152.76%
EPS beat(12)8
Avg EPS beat(12)-32.69%
EPS beat(16)10
Avg EPS beat(16)-9.5%
Revenue beat(2)2
Avg Revenue beat(2)2.41%
Min Revenue beat(2)1.67%
Max Revenue beat(2)3.14%
Revenue beat(4)2
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)3.14%
Revenue beat(8)3
Avg Revenue beat(8)-1.94%
Revenue beat(12)6
Avg Revenue beat(12)0.31%
Revenue beat(16)10
Avg Revenue beat(16)3.23%
PT rev (1m)16.21%
PT rev (3m)27.48%
EPS NQ rev (1m)231.34%
EPS NQ rev (3m)129.63%
EPS NY rev (1m)0%
EPS NY rev (3m)244.88%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE 7.62
Fwd PE 33.92
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.39
EV/EBITDA 93.14
EPS(TTM)2.31
EY13.12%
EPS(NY)0.52
Fwd EY2.95%
FCF(TTM)-16.11
FCFYN/A
OCF(TTM)-3.52
OCFYN/A
SpS9.23
BVpS12.68
TBVpS12.68
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA -12.09%
ROE -87.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.71%
FCFM N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 4.72
Debt/FCF N/A
Debt/EBITDA 73.25
Cap/Depr 428.74%
Cap/Sales 136.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.02
Altman-Z -0.07
F-Score3
WACC5.17%
ROIC/WACCN/A
Cap/Depr(3y)457.15%
Cap/Depr(5y)441.02%
Cap/Sales(3y)111.53%
Cap/Sales(5y)108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)136.26%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%94.55%
EPS Next Y-18.68%
EPS Next 2Y-33.95%
EPS Next 3Y-23.37%
EPS Next 5Y31.82%
Revenue 1Y (TTM)3.27%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%8.68%
Revenue Next Year9.86%
Revenue Next 2Y9.35%
Revenue Next 3Y11.22%
Revenue Next 5Y10.09%
EBIT growth 1Y29.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.88%
EBIT Next 3Y42.76%
EBIT Next 5Y30.2%
FCF growth 1Y-12.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.68%
OCF growth 3YN/A
OCF growth 5YN/A